Collegium Pharmaceutical
COLL
COLL
174 hedge funds and large institutions have $865M invested in Collegium Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 59 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 178 → 174 (-4)
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
82% less call options, than puts
Call options by funds: $239K | Put options by funds: $1.3M
Holders
174
Holding in Top 10
3
Calls
$239K
Puts
$1.3M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$6.09M | |
| 3 | +$3.64M | |
| 4 |
Millennium Management
New York
|
+$3.17M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.49M |
Top Sellers
| 1 | -$9.37M | |
| 2 | -$5.59M | |
| 3 | -$4.38M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$4.37M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$4.25M |